Biotechnology
Thai companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, WuXi Biologics (Cayman) Inc. Units Thailand Depositery Receipt Repr 0.01 Sh ranks as the top gainer, and Medeze Group Public Company Limited sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGN06Amgen Inc Shs Thailand Depositary Receipts Repr 1 ShDR | 8.71 T THB | 3.86 THB | +2.12% | 2.91 K | 0.02 | 0.01 | 580.13 THB | +38.14% | 2.08% | Health technology | No rating |
 WUXI13WuXi Biologics (Cayman) Inc. Units Thailand Depositery Receipt Repr 0.01 ShDR | 853.13 B THB | 3.02 THB | +2.72% | 310 | 0.07 | 0.53 | 5.65 THB | +28.04% | 0.00% | Health technology | No rating |
| WUXI06WuXi Biologics (Cayman) Inc. Units Thailand Depositery Receipts Repr 0.01 Sh DR | 853.13 B THB | 5.10 THB | −1.92% | 27.77 K | 0.20 | 0.90 | 5.65 THB | +28.04% | 0.00% | Health technology | No rating |
 CRSP03CRISPR Therapeutics AG Shs Thailand Depositary Receipts Repr 1 ShDR | 169.04 B THB | 3.32 THB | +2.47% | 114 | 0.00 | — | −0.31 THB | +17.19% | 0.00% | Health technology | No rating |
 MEDEZE.RMedeze Group Public Company Limited NVDRDR | 6.41 B THB | 5.60 THB | −6.67% | 1.21 M | 5.88 | 42.26 | 0.13 THB | −64.29% | 2.67% | Health technology | No rating |
| MEDEZEMedeze Group Public Company Limited | 6.41 B THB | 5.60 THB | −6.67% | 1.21 M | 5.88 | 42.26 | 0.13 THB | −64.29% | 2.67% | Health technology | Buy |